Cell phone makers Samsung and Panasonic may continue to use Broadcom Corp. chips without the threat of patent infringement suits from Qualcomm Inc., Broadcom said Monday.
France joined in with European Union officials on Monday in expressing disappointment with the United States’ new farm bill proposal, saying it had hoped for more ambitious cuts in domestic subsidies that it alleges distort the global market.
Thailand is forging ahead in its controversial battle to slash the cost of drugs, with a top health official on Monday warning the nation will issue more compulsory licenses for patented medicines unless pharmaceutical companies lower their prices.
Underscoring differences in trademark law between the United States and China, a U.S. apple industry group has lost its bid in China to use “Washington” in a brand name, on the grounds that the word is too well-known as a geographic term.
The European Union has fired back in its long-running dispute with the United States over subsidies for Boeing Inc. and Airbus, filing a response to claims the U.S. made in an earlier complaint filed with the World Trade Organization.
The European trade chief on Friday insisted on the need for strict, cross-national regulations to help stabilize the energy market and encourage the use of clean, green technology – areas he said now exist in an “international legal vacuum.”
The growing spat between rival software companies SiRF Technology and Global Locate over global positioning chips has gone to the U.S. International Trade Commission.
After suffering a blow in its bid to protect the rights to Viagra in China, Pfizer Inc. is appealing a Beijing court ruling that the drug maker can no longer use the name Wei Ge, or “mighty brother,” to market its erectile dysfunction drug.
As part of an effort to recruit more lawyers with experience in cases before the International Trade Commission, Jones Day has snagged a longtime intellectual property attorney from Venable LLC to join the firm.
Japanese chip maker Renesas Technology Corp. has bombarded Korean rival Samsung Electronics Co. Ltd. with legal actions over the last couple of weeks for allegedly infringing its memory patents.
Pfizer Inc. has suffered a blow in its bid to protect the rights to Viagra in China, with a Beijing court ruling that the drug maker can no longer use the name Wei Ge, or “mighty brother,” to market the erectile dysfunction drug because a Chinese pharmaceutical company has already registered the brand.
Loeb & Loeb LLP has snapped up three partners from a patent litigation group for the firm’s intellectual property litigation team.
The U.S. Court of Appeals for the Federal Circuit has shot down a doctor’s request to pursue foreign patent infringement claims in the U.S. courts.
Calling for stronger cuts in domestic farm subsidies and less distortion of the global market, the European Commission expressed disappointment with a new farm bill the United States proposed on Wednesday.
Hoping to expand its intellectual property practice to other parts of the world, Foley & Lardner LLP is planning to open an office in China.
The Thai government said Monday that is has approved the compulsory licensing of two drugs, one for treating heart disease and one for HIV/AIDS, paving the way for the sale of generic versions of the drugs in that country and effectively breaking their patents.
After nine days of trial and only six hours of deliberation, a jury unanimously ruled Friday that Qualcomm Inc.’s two video compression patents are valid, but Broadcom Corp. did not infringe upon them.
The Thai government is reportedly set to unveil plans to issue compulsory licensing for two high-cost drugs amid widespread criticism from multinational drug companies.
Sonnenschein Nath & Rosenthal LLP plans to extend the reach of its intellectual property practice with an office in Silicon Valley to move the firm closer to the area’s booming technology industry.
The protest against the United States’ allegedly illegal aid to its corn farmers has grown significantly louder, with 32 countries joining Canada in the dispute at the World Trade Organization.